A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Clinical trial NCT07241390 · RECRUITING
Trial details
- NCT number
- NCT07241390
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2031-08-01
- Enrollment
- 7140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.